teclistamab
janssen,genmab
['multiplemyeloma', 'majestec-1', 'janssen']
for us #hcps at #ash22, see dr. diana cortes-selva present translational research data from the majestec-1 phase 1/2 study of a bcmaxcd3 bispecific antibody in patients with relapsed or refractory #multiplemyeloma. 
Dedicated to sharing Janssen Oncology scientific communications for US HCPs. Account run by Janssen Global Services LLC. Review our Guidelines: https://t.co/uieWByQjn3.